These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15279723)

  • 1. Latanoprost eye drops increase concentration of glycosaminoglycans in posterior rabbit sclera.
    Trier K; Ribel-Madsen SM
    J Ocul Pharmacol Ther; 2004 Jun; 20(3):185-8. PubMed ID: 15279723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit.
    Sjöquist B; Basu S; Byding P; Bergh K; Stjernschantz J
    Drug Metab Dispos; 1998 Aug; 26(8):745-54. PubMed ID: 9698288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and ultrastructural changes in rabbit sclera after treatment with 7-methylxanthine, theobromine, acetazolamide, or L-ornithine.
    Trier K; Olsen EB; Kobayashi T; Ribel-Madsen SM
    Br J Ophthalmol; 1999 Dec; 83(12):1370-5. PubMed ID: 10574816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of latanoprost in the cynomolgus monkey. 3rd communication: tissue distribution after topical administration on the eye studied by whole body autoradiography. Glaucoma Research Laboratories.
    Sjöquist B; Johansson A; Stjernschantz J
    Arzneimittelforschung; 1999 Mar; 49(3):240-9. PubMed ID: 10219468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced FGF-2 movement through human sclera after exposure to latanoprost.
    Aihara M; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2554-9. PubMed ID: 11581197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera.
    Weinreb RN; Lindsey JD; Marchenko G; Marchenko N; Angert M; Strongin A
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4368-77. PubMed ID: 15557445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes.
    Loch C; Zakelj S; Kristl A; Nagel S; Guthoff R; Weitschies W; Seidlitz A
    Eur J Pharm Sci; 2012 Aug; 47(1):131-8. PubMed ID: 22659372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical changes in rabbit sclera following destruction of pigment epithelium.
    Trier K; Olsen EB; Prause JU
    Acta Ophthalmol (Copenh); 1991 Oct; 69(5):645-8. PubMed ID: 1776420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma.
    Kashiwagi K; Ito K; Haniuda H; Ohtsubo S; Takeoka S
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5629-37. PubMed ID: 23868986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical application of 0.005% latanoprost increases episcleral venous pressure in normal dogs.
    Tsai S; Miller PE; Struble C; Howard S; Almazan A; Burke JA; Hughes PM; Li H; Conforti P; Lee SS; Robinson MR
    Vet Ophthalmol; 2012 Mar; 15 Suppl 1():71-8. PubMed ID: 22129101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pilocarpine-induced ciliary body contraction affects the elastic modulus and collagen of cornea and sclera in early development.
    Xie Y; Wang M; Cong Y; Cheng M; Wang S; Wang G
    Biomed Pharmacother; 2018 Dec; 108():1816-1824. PubMed ID: 30372887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans.
    Ishii K; Tomidokoro A; Nagahara M; Tamaki Y; Kanno M; Fukaya Y; Araie M
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2957-63. PubMed ID: 11687542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of scleral macromolecular permeability with prostaglandins.
    Weinreb RN
    Trans Am Ophthalmol Soc; 2001; 99():319-43. PubMed ID: 11797317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
    Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
    Exp Eye Res; 2011 Sep; 93(3):250-5. PubMed ID: 21396362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of latanoprost acid and pilocarpine on cultured rabbit ciliary muscle cells.
    Zhong Y; Gao J; Ye W; Huang P; Cheng Y; Jiao Q
    Ophthalmic Res; 2007; 39(4):232-40. PubMed ID: 17622744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium hyaluronate decreases ocular surface toxicity induced by benzalkonium chloride-preserved latanoprost: an in vivo study.
    Yu F; Liu X; Zhong Y; Guo X; Li M; Mao Z; Xiao H; Yang S
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3385-93. PubMed ID: 23620425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
    Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of latanoprost when stored at room temperature.
    Mochizuki H; Itakura H; Takamatsu M; Kiuchi Y
    Hiroshima J Med Sci; 2008 Jun; 57(2):69-72. PubMed ID: 18717189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional glycosaminoglycans composition of the human sclera.
    Trier K; Olsen EB; Ammitzbøll T
    Acta Ophthalmol (Copenh); 1990 Jun; 68(3):304-6. PubMed ID: 2392906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.